What does Serum Glycosylated Apolipoprotein J mean in a heart attack?-----Correlation of serum glycosylated apolipoprotein J with acute myocardial infarction
yao, r.; Ren, M.; Dong, H.; Wang, H.; Jia, W.; Ding, X.; Fu, K.; Wang, A.; Zhu, X.; gong, l.; Zhong, L.
Show abstract
BackgroundThere are few myocardial damage markers that could be used to diagnose acute myocardial infarction(AMI) or assess its severity, especially glycosylated apolipoprotein J(ApoJ-Glyc) has demonstrated superiority in cardiomyocytes and animal STEMI models in the early stages of myocardial ischemia(MI). We aimed to excavate the potential role of ApoJ-Glyc as a protein marker in the pathogenesis of AMI in humans and its added value in the evolution of the disease. Methods and ResultsELISA was used to determine the serum concentration of ApoJ-Glyc in 163 patients enrolled by the criteria. Statistical analysis could used to discuss the relationship between ApoJ-Glyc and AMI. Compared to control groups, serum ApoJ-Glyc levels decreased by 36% and 37% in early AMI patients and AMI patients, respectively (P<0.0001), showing a higher discriminant value for early diagnosis and diagnosis of AMI [area under the curve (AUC) : 0.871 and 0.886, P< 0.0001]. For the first time, we demonstrated that ApoJ-Glyc was not statistically significant in the comparative difference between NSTEMI and STEMI groups (P> 0.05). Patients with gradually declining ApoJ-Glyc had a higher Grace Risk Scores. Subsequent studies have also demonstrated that more MACCE did occur with a 6-month follow-up(P<0.05). ConclusionsApoJ-Glyc which serve as an alarm bell for the detection of early ischaemia, may be a new biomarker for AMI. ApoJ-Glyc can assess the severity of myocardial infarction. The continuous decrease of serum ApoJ-Glyc suggests an increase in the risk of post-AMI ischaemia and the onset of unpredictable MACCE. Graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/23291631v1_ufig1.gif" ALT="Figure 1"> View larger version (41K): org.highwire.dtl.DTLVardef@1d3b996org.highwire.dtl.DTLVardef@13d4482org.highwire.dtl.DTLVardef@15cf203org.highwire.dtl.DTLVardef@114de20_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services 97%
- Reactivation of atrium genes is a primer for heart infarction or regeneration 95%
- Molecular mechanisms of Cardiac Injury associated with myocardial SARS-CoV-2 infection 95%
Similar papers in this journal
- Age-stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in Japan 97%
- Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia. The Randomized RAIN-FLOW Study 96%
- Association of free fatty acids with long-term adverse outcomes in patients with premature myocardial infarction: a prospective cohort study 95%
Similar papers in this journal
- Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis 96%
- Postoperative glycemic variability as a predictor for one-year mortality following coronary artery bypass grafting: A retrospective cohort study 95%
- Catalpol inhibits HHcy-induced EndMT in endothelial cells by modulating ROS/NF-κB signaling 94%
Similar papers in this journal
- Lipid profiles in ST-elevation myocardial infarction with and without diabetes: the gap between prescription and targets 96%
- Utility of the CHADS-P 2 A 2 RC score for estimating net adverse clinical events in chronic coronary syndrome patients without atrial fibrillation: insights from the CLIDAS-PCI 96%
- Temporal Variations in Ischemic and Bleeding Event Risks after Acute Coronary Syndrome during Dual Antiplatelet Therapy 95%
Similar papers in this journal
- Risk Prediction of Coronary Artery Spasm in Patients Without Obstructive Coronary Artery Disease Using a Comprehensive Clinical, Laboratory and Echocardiographic Diagnostic Score 96%
- Screening for Right Ventricular Dysfunction in the Emergency Department Using a Smartphone ECG Analysis Application: An External Validation Study with Acute Pulmonary Embolism Patients 94%
- Role of miRNAs induced by oxidized low-density lipoproteins in coronary artery disease: the REGICOR Study. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.